Revive Therapeutics Ltd. (RVV.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
Nov 13, 16:00
Revive Therapeutics Enterprise Value : 6.520M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 6.520M |
| November 12, 2026 | 8.699M |
| November 11, 2026 | 6.520M |
| November 10, 2026 | 8.699M |
| November 09, 2026 | 6.520M |
| November 06, 2026 | 8.699M |
| November 05, 2026 | 6.520M |
| November 04, 2026 | 8.699M |
| November 03, 2026 | 6.520M |
| November 02, 2026 | 8.699M |
| October 30, 2026 | 8.699M |
| October 29, 2026 | 6.520M |
| October 28, 2026 | 8.699M |
| October 27, 2026 | 8.699M |
| October 26, 2026 | 8.699M |
| October 23, 2026 | 8.699M |
| October 22, 2026 | 8.699M |
| October 21, 2026 | 8.699M |
| October 20, 2026 | 10.88M |
| October 19, 2026 | 10.88M |
| October 16, 2026 | 10.88M |
| October 15, 2026 | 13.06M |
| October 14, 2026 | 10.88M |
| October 13, 2026 | 13.06M |
| October 09, 2026 | 10.88M |
| Date | Value |
|---|---|
| October 08, 2026 | 13.06M |
| October 07, 2026 | 10.88M |
| October 06, 2026 | 13.06M |
| October 05, 2026 | 13.06M |
| October 02, 2026 | 10.88M |
| October 01, 2026 | 10.88M |
| September 30, 2026 | 10.88M |
| September 29, 2026 | 13.06M |
| September 28, 2026 | 8.699M |
| September 25, 2026 | 8.699M |
| September 24, 2026 | 8.699M |
| September 23, 2026 | 10.88M |
| September 22, 2026 | 8.699M |
| September 21, 2026 | 10.88M |
| September 18, 2026 | 8.699M |
| September 17, 2026 | 8.699M |
| September 16, 2026 | 8.699M |
| September 15, 2026 | 8.699M |
| September 14, 2026 | 6.520M |
| September 11, 2026 | 10.88M |
| September 10, 2026 | 10.88M |
| September 09, 2026 | 10.88M |
| September 08, 2026 | 10.88M |
| September 04, 2026 | 10.88M |
| September 03, 2026 | 13.06M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| HLS Therapeutics, Inc. | 154.12M |
| Bausch Health Cos., Inc. | 31.74B |
| Cipher Pharmaceuticals, Inc. | 336.68M |
| BioSyent, Inc. | 195.94M |
| Knight Therapeutics, Inc. | 1.082B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.0033M |
| Total Expenses (Quarterly) | -0.0033M |
| Earnings Yield | -16.67% |
| Normalized Earnings Yield | -16.67 |